期刊文献+

慢性心力衰竭患者血浆Elabela水平变化及意义 被引量:11

Change and significance of plasma Elabela in patients with chronic heart failure
原文传递
导出
摘要 目的探讨不同NYHA心功能分级慢性心力衰竭患者血浆Elabela(ELA)表达水平差异及意义。方法慢性心力衰竭患者62例,其中NYHA心功能Ⅰ级17例,Ⅱ级14例,Ⅲ级18例,Ⅳ级13例,入院次日采集空腹静脉血,采用电化学发光法检测血浆N末端脑钠肽前体(nitrogen-terminal pro-brain natriuretic peptide,NT-proBNP)水平,采用ELISA法测定血浆ELA水平,应用彩色多普勒超声测定左室射血分数(left ventricular ejection fraction,LVEF);Spearman相关分析血浆ELA水平与NT-proBNP、LVEF的相关性。结果血浆ELA、NT-proBNP水平在NYHA心功能Ⅱ级患者[4.69(2.50,5.87)μg/L、1 022(776,1 760)ng/L]、Ⅲ级患者[8.66(6.81,9.65)μg/L、3 265(2 800,4 115)ng/L]、Ⅳ级患者[23.37(16.91,37.88)μg/L、7 817(6 959,9 636)ng/L]高于Ⅰ级患者[2.75(1.87,3.82)μg/L、318(219,537)ng/L],且NYHA心功能Ⅳ级患者高于Ⅱ级、Ⅲ级患者,Ⅲ级患者高于Ⅱ级患者(P<0.05);NYHA心功能Ⅲ、Ⅳ级患者LVEF水平[(37.33±4.63)%、(34.00±4.47)%]低于Ⅰ级患者[(45.25±4.44)%](P<0.05),Ⅲ级与Ⅳ级、Ⅰ级与Ⅱ级患者LVEF水平比较差异无统计学意义(P>0.05);Spearman相关分析结果显示,慢性心力衰竭患者血浆ELA水平与NT-proBNP呈正相关(r=0.86,P<0.001),与LVEF水平呈负相关(r=-0.61,P<0.001)。结论随NYHA心功能分级增高,慢性心力衰竭患者血浆ELA表达明显增高,血浆ELA可作为判断心力衰竭严重程度的生物学标志物。 Objective To observe the changes of plasma levels of Elabela(ELA)in different New York Heart Association(NYHA)class in patients with chronic heart failure.Methods Sixty-two patients with chronic heart failure were divided into NYHA classⅠ group(n=17),classⅡ group(n=14),classⅢ group(n=18)and class Ⅳ group(n=13). The plasma nitrogen-terminal pro-brain natriuretic peptide(NT-proBNP) was detected by electrochemiluminescence immunoassay,ELA was detected by ELISA,and left ventricular ejection fraction(LVEF)was determined by color Doppler ultrasound.Spearman correlation analysis was used to analyze the relationship of ELA with NT-proBNP and LVEF.Results The levels of NT-proBNP and ELA were the highest in NYHA classⅣ group(23.37(16.91,37.88)μg/L,7 817(6 959,9 636)ng/L),followed by NYHA classⅢ group(8.66(6.81,9.65)μg/L,3 265(2 800,4 115)ng/L),NYHA classⅡ group(4.69(2.50,5.87)μg/L,1 022(776,1 760)ng/L),and NYHA classⅠgroup(2.75(1.87,3.82)μg/L,318(219,537)ng/L)in turns(P<0.05).The LVEF level was significantly lower in NYHA classⅢ group((37.33±4.63)%)and NYHA classⅣ group((34.00±4.47)%)than that in NYHA classⅠgroup((45.25±4.44)%)(P<0.05),and showed no significant difference between NYHA classⅢ group andⅣ group and between NYHA class Ⅰ group and Ⅱ group(P>0.05).Spearman correlation analysis results showed that the plasma ELA level was positively correlated with NT-proBNP(r=0.86,P<0.001),and negatively correlated with LVEF in patients with chronic heart failure(r=-0.61,P<0.001).Conclusion The plasma ELA level increases obviously with the increase of NYHA classification,and it might be used as a sensitive biomarker for evaluating the severity of heart failure.
出处 《中华实用诊断与治疗杂志》 2017年第9期899-901,共3页 Journal of Chinese Practical Diagnosis and Therapy
基金 国家自然科学基金(81570365) 南京市医学科技发展项目(YKK10086)
关键词 慢性心力衰竭 NYHA心功能分级 Elabela N末端脑钠肽前体 Chronic heart failure NYHA Elabela nitrogen-terminal pro-brain natriuretic peptide
  • 相关文献

参考文献2

二级参考文献24

  • 1Richard W Troughton, Christopher M Frampton, Timothy G Yandle, et al. Treatment of heart failure guided by plasma aminoterminal brain na- triuretic peptide( N-BNP ) concentrations [ J ]. The Lancet, 2000,355 (9210) :1126-1130.
  • 2Vuoheenaho O, Ala-Kopsala M, Ruskoaho H. BNP as a biomarker in heart disease [ J ]. Advances in Clinical Chemistry,2005 ( 40 ) : 1-36.
  • 3Dries DL, Stevenson LW. Brain natriuretic peptide as bridge to therapy for heart failure [ J ]. The Lancet,2000,355 (9210) : 1112-1113.
  • 4Ishii J, Nomura M, Nakamura Y. Risk stratification using a combination of cardiac troponin T and briain natriuretic peptide in patients hospi- talized for worsening chronic heart failure [ J ]. American Journal of Cardiology ,2002,89 (6) :691-695.
  • 5Maisel A. B-type natriuretic peptide levels:Diagnostic and prognostic in congestive heart failure : what is next [ J ]. Circulation, 2002,105 ( 20 ) : 2328 -2331.
  • 6McCullough PA, Sandberg KR. B-type natriuretie peptide and renal disease [ J ]. Heart Failure Reviews,2003,8 (4) :355-358.
  • 7Miller WL, Hartman KA. Response of novel biomarkers to BNP infu- sion in patients with deeompensated heart failure : a multimarker para- digm[J]. J Cardiovasc Transl Res,2009,2(4) :526-535.
  • 8Hardy CI, Weiss RG, Bottomley PA. Altered myocardial high energy phosphate metabolites in patients with dilated cardiomyopathy[ J ]. A- merican Heart Journal, 1991,122 (3) :795-801.
  • 9无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3712
  • 10木胡牙提,杨玉春,马依彤,林涛,刘志强,何鹏义.连续性肾脏替代治疗对慢性重度心力衰竭患者N端利钠肽前体及C反应蛋白的影响[J].中华实用诊断与治疗杂志,2010,24(8):754-755. 被引量:8

共引文献19

同被引文献55

引证文献11

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部